SNORD67: SNORD67 is a small nucleolar RNA (snoRNA) that has been identified as one of the genes sharing a common function in recognized gene clusters [PMC6839856]. It has been found to be upregulated in ER positive RT-treated cases and associated with better breast cancer-specific survival (BCSS) [PMC9803687]. SNORD67, along with SNORD60 and SCARNA11, has been identified as a prominent predictive candidate for invasive local breast cancer [PMC9803687]. It has also been reported to be upregulated in cancer tissue compared to normal tissue and linked to better outcomes in other types of cancer [PMC9803687]. SNORD67 is one of the genes that replace ACA35 in the corresponding sequences from scaRNAs [PMC6023535]. Additionally, SNORD67 is associated with site-specific bone mineral density (BMD) and is one of the genes found to be slightly upregulated in TA and TS [PMC4374695] [PMC9917053]. It is also linked to other genes such as ARHGAP1, LRP4, ATG13, CKAP5, ZNF408 through complete linkage disequilibrium with SNP rs3136441 of the F2 gene [PMC8868589]. Furthermore, SNORD67 modifies U6 snRNA along with other snoRNAs such as SNORD7 and SNORD94 [PMC6894857] [PMC8599867]. References: - PMC6839856 - PMC9803687 - PMC6023535 - PMC4374695 - PMC8868589 - PMC6894857 - PMC8599867 - PMC9917053